Physician
Fort Myers Pediatrics LLC
Fort Myers Pediatrics LLC was paid $2.23M by Medicaid between Jan 2019 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoFORT MYERS PEDIATRICS LLC
FORT MYERS, FL 33912
FORT MYERS, FL 33912
33aNPI1972823409assigned 06/07/2010
33bProvider typePediatrics Physician
28Total paid$2.23M
24GClaims84,257
24DCodes billed61
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#148 of 971
Median peer was paid$238K
This provider vs. median9.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 20,635 | $517K | |
| 2020 | 13,969 | $351K | |
| 2021 | 11,800 | $399K | |
| 2022 | 12,345 | $412K | |
| 2023 | 15,496 | $321K | |
| 2024incomplete | 10,012 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 16,166 | 14,750 | $699K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 21% | 4,965 | 4,726 | $459K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 14% | 3,939 | 3,845 | $319K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 13% | 3,536 | 3,394 | $298K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.3% | 1,758 | 1,685 | $141K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.8% | 1,669 | 1,609 | $86K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 1,440 | 1,387 | $49K |
| 90670 | 2.1% | 2,804 | 2,665 | $47K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.8% | 12,341 | 11,713 | $40K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.4% | 11,675 | 7,135 | $30K |
| 90651 | <1% | 608 | 576 | $9K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 95 | 78 | $7K |
49 more codes
| 90686 | <1% | 3,289 | $7K | |
| 99381 | <1% | 85 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 315 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 44 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 571 | $3K |
| 99383 | <1% | 25 | $2K | |
| 90710 | <1% | 196 | $2K | |
| 90734 | <1% | 595 | $2K | |
| 90671 | <1% | 294 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,404 | $2K |
| 99384 | <1% | 16 | $2K | |
| 90723 | <1% | 1,643 | $1K | |
| 90620 | <1% | 673 | $828.21 | |
| 90461 | <1% | 86 | $828.00 | |
| 90655 | <1% | 1,883 | $747.18 | |
| 90685 | <1% | 354 | $737.44 | |
| 90633 | <1% | 1,772 | $702.14 | |
| 92552 | <1% | 1,004 | $534.74 | |
| 90707 | <1% | 191 | $408.75 | |
| 83655 | <1% | 701 | $309.98 | |
| 90716 | <1% | 165 | $246.38 | |
| 90649 | <1% | 234 | $209.51 | |
| 90681 | <1% | 878 | $185.00 | |
| 90474 | <1% | 19 | $181.12 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,227 | $130.80 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $130.00 |
| 90696 | <1% | 184 | $96.18 | |
| 97803 | <1% | 316 | $77.90 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $74.13 |
| 90700 | <1% | 218 | $65.60 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 114 | $53.00 |
| 90647 | <1% | 707 | $50.00 | |
| 90715 | <1% | 111 | $40.00 | |
| 87807 | <1% | 96 | $15.35 | |
| 90648 | <1% | 876 | $10.00 | |
| 99173 | 0% | 1,148 | $0.00 | |
| 90621 | 0% | 118 | $0.00 | |
| 90473 | 0% | 149 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 81002 | 0% | 34 | $0.00 | |
| 99072 | 0% | 60 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 31 | $0.00 |
| 90697 | 0% | 15 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 1,106 | $0.00 |
| 85018 | 0% | 169 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 24 | $0.00 |
| 90698 | 0% | 39 | $0.00 | |
| 90677 | 0% | 14 | $0.00 | |
| 94760 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOTERO, ROLANDO (GENERAL MANAGER)